National Institutes of Health: all 11,571 studies

Page 48 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Imaging Biomarkers in Parkinson s DiseaseCompletedNCT01496599
• Service Member Fatigue and Lack of Motivation Following ConcussionCompletedNCT01496586
• Registry for the Atopic Dermatitis Research NetworkCompletedNCT01494142
• Noninvasive Study of Brain Connectivity With EEG and NIRSCompletedNCT01493804
• CDB-2914 for Abnormal Uterine Bleeding in Premenopausal WomenWithdrawnNCT01493791Early Phase 1
• Measuring Effects of Alcohol on Brain ChemistryTerminatedNCT01492933
• Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant WomenWithdrawnNCT01490671Phase 2
• Combined Deep Brain Stimulation for Parkinson's DiseaseWithdrawnNCT01485276Phase 1/2
• Analysis of Visual-Motor Task Electrophysiological Activity During Deep Brain Stimulation for Treatment-Resistant Movement DisordersWithdrawnNCT01485263
• A Cross-Cultural Assessment of the Motivations of Healthy Participants in Phase I ResearchCompletedNCT01485250
• Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney CancerActive, not recruitingNCT01480154Phase 1
• Providing Access to Cord Blood Units for TransplantsWithdrawnNCT01479582Phase 2
• Pericardiocentesis With Magnetic Resonance ImagingTerminatedNCT01479569Phase 1
• Antiretroviral Drug Interaction Study in Volunteers With HIVCompletedNCT01479361Phase 1
• Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected AdultsCompletedNCT01479296Phase 1
• Octanoic Acid for Essential TremorCompletedNCT01468948Phase 1
• Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive FunctioningCompletedNCT01468935
• The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive IrradiationCompletedNCT01468883Phase 3
• Physical and Emotional Health of Caregivers for People Who Have Had Stem Cell TransplantsCompletedNCT01468857
• Childhood Asthma Reduction StudyWithdrawnNCT01468805Not applicable
• AZD7451 for Recurrent GliomasCompletedNCT01468324Phase 1
• Intestine Bacteria and Breast Cancer RiskCompletedNCT01461070
• Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT01459380Phase 1
• Effects of Hormone Stimulation on Brain Scans for Cushing s DiseaseCompletedNCT01459237Early Phase 1
• Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and ChildrenCompletedNCT01459198Phase 1
• Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic CancerTerminatedNCT01457131Phase 1
• Tabectedin to Treat Children and Adolescents With CancerCompletedNCT01453283Phase 1
• Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular DystrophyCompletedNCT01451281
• Vitamin D Levels in the Skin of Healthy Subjects After Oral SupplementationCompletedNCT01447355Phase 1
• Ultra Low Dose Interleukin-2 in Healthy VolunteersCompletedNCT01445561Phase 1
• ABT-888 Plus Metronomic Cyclophosphamide to Treat CancerCompletedNCT01445522Phase 1
• Dasatinib in Combination With Bevacizumab to Treat Advanced Solid TumorsCompletedNCT01445509Phase 1
• Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain MetastasesCompletedNCT01445483
• AZD2281 Plus Carboplatin to Treat Breast and Ovarian CancerCompletedNCT01445418Phase 1
• Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck CancerCompletedNCT01445405Phase 1
• SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural MesotheliomaTerminatedNCT01445392Phase 1
• Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant CancerCompletedNCT01445379Phase 1
• Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell LymphomaTerminatedNCT01445340Phase 1
• Analysis of Data Collected From Individuals Administered Neurobehavioral AssessmentsCompletedNCT01445314
• Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System TumorsCompletedNCT01445288
• Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation ProceduresCompletedNCT01445158
• An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV InfectionCompletedNCT01445145
• Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell TransplantationCompletedNCT01445132Phase 1
• A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid TumorsCompletedNCT01445106Phase 1
• 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast CancerTerminatedNCT01445054Early Phase 1
• Prevention of Iron Deficiency in Breastfed InfantsCompletedNCT01444261Phase 4
• Teenagers, Drug Addiction, and Reward and Impulse ControlWithdrawnNCT01443949
• Experimental AD4-H5-VTN Vaccine in Healthy VolunteersCompletedNCT01443936Phase 1
• Weight Management Interactions in a Virtual Clinical EnvironmentCompletedNCT01443910
• Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza VaccineCompletedNCT01443663Phase 1
• Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant WomenWithdrawnNCT01443117Phase 2
• Experimental PfSPZ Vaccine in Adults Without MalariaCompletedNCT01441167Phase 1
• Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer TreatmentCompletedNCT01441154
• Genetics and Pain Severity in Sickle Cell DiseaseCompletedNCT01441141
• -02341066 and PF-00299804 for Advanced Non-Small Cell Lung CancerTerminatedNCT01441128Phase 1
• DAS181 in Patients With ParainfluenzaWithdrawnNCT01441024Phase 2
• Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial CancerCompletedNCT01440998Phase 1
• Initial Study of Fenoterol as a Treatment for Heart FailureCompletedNCT01440335Phase 1
• Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected AdultsCompletedNCT01438606Phase 1
• Breath Test for Chemicals (Volatile Organic Compounds)CompletedNCT01437033
• SCH708980 With and Without AmBisome for Visceral LeishmaniasisWithdrawnNCT01437020Phase 1/2
• TKM 080301 for Primary or Secondary Liver CancerCompletedNCT01437007Phase 1
• Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus VaccineCompletedNCT01436422Phase 1
• Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)CompletedNCT01434381Phase 1
• Veliparib and Dinaciclib in Treating Patients With Advanced Solid TumorsActive, not recruitingNCT01434316Phase 1
• Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab OnlyCompletedNCT01434303Phase 1
• Studying Childhood-Onset HemidystoniaCompletedNCT01432899
• Muscle Biopsies in Healthy VolunteersTerminatedNCT01431677Not applicable
• Interferon Responses in Eczema HerpeticumCompletedNCT01429311
• Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis CCompletedNCT01428700
• Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib MesylateTerminatedNCT01426334Phase 1
• Mood and Insulin Resistance in Adolescents At-Risk for DiabetesCompletedNCT01425905Phase 2
• Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals PatientsCompletedNCT01424878
• Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)CompletedNCT01423825Phase 1
• The NIH UNI Study: Urea Cycle Disorders, Nutrition and ImmunityTerminatedNCT01421888
• Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care TreatmentStatus unknownNCT01421862
• Imaging of Brain Receptors Using (11C)mGlu1TerminatedNCT01420952Phase 1
• Developing Therapies for Traumatic Brain InjuryTerminatedNCT01420939
• Ultrasound and Other Images of Artery BlockagesTerminatedNCT01419574
• ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney ProblemsWithdrawnNCT01419548Phase 1
• Treadmill Training at Constant or Different Speeds for People With Traumatic Brain InjuryTerminatedNCT01419522Phase 3
• Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk NeuroblastomaCompletedNCT01418495
• NHS-IL12 for Solid TumorsCompletedNCT01417546Phase 1
• A Natural History Study of Patients With GNE Myopathy and GNE-Related DiseasesCompletedNCT01417533
• Clinical and Pathophysiological Investigations Into Erdheim Chester DiseaseCompletedNCT01417520
• MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell LymphomaWithdrawnNCT01415765Phase 1/2
• Amatuximab for High Mesothelin CancersTerminatedNCT01413451Early Phase 1
• Bevacizumab With or Without Surgery for Adult GlioblastomasWithdrawnNCT01413438Phase 2
• A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz SyndromeWithdrawnNCT01413425
• Effect of Music on Pain and Anxiety After SurgeryTerminatedNCT01409044Phase 3
• Testing Devices That Involve the Sense of Touch in Subjects With Traumatic Brain InjuryCompletedNCT01404494
• Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin LymphomaCompletedNCT01403415Phase 1
• Brain Functions Underlying Visuospatial Attention Deficits in SchizophreniaCompletedNCT01399437
• Shigella Sonnei OSPC-rDT Conjugate VaccineWithdrawnNCT01399424Phase 1
• Agricultural Health Study Follow-upCompletedNCT01399411
• Imaging of CB1 Receptors Using (11C)SD5024TerminatedNCT01399398Phase 1
• Nitric Oxide and Sickle Cell PainTerminatedNCT01393847
• The Role of Family Functioning in Promoting Adaptation in Siblings of Individuals With Duchenne Muscular Dystrophy (DMD)TerminatedNCT01386515
• CT-011 and p53 Genetic Vaccine for Advanced Solid TumorsWithdrawnNCT01386502Phase 1
• Immune Responses to Two Experimental HIV Vaccines in Healthy AdultsCompletedNCT01386489Phase 1

← National Institutes of Health overview and focus areas